You have free access to this content

American Journal of Transplantation

Cover image for Vol. 11 Issue 4

April 2011

Volume 11, Issue 4

Pages 641–874

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 641–642)

      SUE PONDROM

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03520.x

      This month, we take an in-depth look at Arizona's decision to deny coverage for certain transplants, and hear responses to the controversial legislation from leaders in the field of transplantation.

  2. Literature Watch

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      LITERATURE Watch (page 643)

      JONATHAN S. BROMBERG

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03521.x

      Members of the Predictive Safety Testing Consortium undertook a comprehensive preclinical study of renal toxins to develop more sensitive and specific biomarkers of renal function and injury. The results are illuminating and point the way to alternative measures of renal injury and function.

  3. Editorials

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Organized Staffing Directed by Intensivists Improves Outcomes for Critically Ill Patients (pages 645–646)

      M. P. Fink

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03472.x

      The best available data support the view that organized staffing of intensive care units, under the direction of intensivists, improves outcomes for critically ill patients. See special article by Ranjan et al on page 670.

    2. You have free access to this content
      Revisiting the Natural History of IF/TA in Renal Transplantation (pages 647–649)

      Sophie Brouard, Karine Renaudin and Jean-Paul Soulillou

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03456.x

      This editorial discusses the natural history of IF/TA, with specific reference to the progress of immunosuppressive regimens and input of molecular phenotyping. See articles by Stegall et al (page 698) and Mengel et al (page 708).

    3. You have free access to this content
      Calculated PRA: A Process Whose Time Has Come or ‘Déjà vu’ All Over Again? (pages 650–651)

      R. A. Bray, C. Murphey and S. Schaub

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03452.x

      The implementation of calculated PRA has been a success and is changing clinical practice; however, the concept is not new and there remains room for improvement. See article by Cecka et al on page 719.

    4. You have free access to this content
      If You're Not Fit, You Mustn't Quit: Observational Studies and Weighing the Evidence (pages 652–653)

      D. L. Segev, A. B. Massie, J. D. Schold and B. Kaplan

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03471.x

      • image

      While observational studies are important in transplantation, inferences from nonrandomized trials that seem contrary to putative biological mechanisms must be made with great care. See article by Molnar et al on page 725.

  4. Minireviews

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Paradoxical Aspects of Rapamycin Immunobiology in Transplantation (pages 654–659)

      I. R. Ferrer, K. Araki and M. L. Ford

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03473.x

      • image
      • image

      The authors review recent findings concerning the at times paradoxical effects of mTOR inhibition through rapamycin on CD4+ and CD8+ T cell responses in transplantation and protective immunity.

    2. You have free access to this content
      Crosstalk between Complement and Toll-like Receptor Activation in Relation to Donor Brain Death and Renal Ischemia-Reperfusion Injury (pages 660–669)

      Jeffrey Damman, Mohamed R. Daha, Willem J. van Son, Henri G. Leuvenink, Rutger J. Ploeg and Marc A. Seelen

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03475.x

      • image
      • image

      This review discusses the innate immune interplay between complement and Toll-like receptor activation in relation to pretransplant renal injury by donor brain death and early posttransplant renal ischemia-reperfusion injury.

      Corrected by:

      Erratum

      Vol. 11, Issue 8, 1759, Version of Record online: 28 JUL 2011

  5. Special Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      American Society of Transplant Surgeons’ White Paper: Impact of Closed ICUs on Transplant Patients’ Care (pages 670–671)

      D. Ranjan, G. Klintmalm, J. Roberts and Members of the Critical Care Task Force, ASTS

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03462.x

      The ASTS takes a stand that the current move towards “closed” ICUs is unwarranted and may be detrimental in the care of transplant patients, and that many transplant surgeons function well in the role of intensivist for their patients. See editorial by Fink on page 645.

    2. You have free access to this content
      Screening and Treatment of Chagas Disease in Organ Transplant Recipients in the United States: Recommendations from the Chagas in Transplant Working Group (pages 672–680)

      P. V. Chin-Hong, B. S. Schwartz, C. Bern, S. P. Montgomery, S. Kontak, B. Kubak, M. I. Morris, M. Nowicki, C. Wright and M. G. Ison

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03444.x

      • image

      A multidisciplinary working group presents evidence-based recommendations for donor screening and follow-up testing and treatment of organ recipients from infected living and deceased donors with Chagas disease.

  6. Meeting Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Report of a Joint ESOT and AST Meeting: Highlights in Biologic Agents and Transplantation (pages 681–686)

      C. C. Baan and R. S. Gaston

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03463.x

      • image

      The authors report on an international meeting focusing on advances in immunology and biologics, jointly sponsored by AST and ESOT, held in Nice, France, in October 2010.

  7. Personal Viewpoints

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept (pages 687–692)

      Arthur J. Matas

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03505.x

      The author questions the significance of calcineurin inhibitors in posttransplant kidney dysfunction. See rhetorical viewpoint by Chapman on page 693.

    2. You have free access to this content
      Chronic Calcineurin Inhibitor Nephrotoxicity—Lest We Forget (pages 693–697)

      J. R. Chapman

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03504.x

      Reviewing the data that lead to the conclusion that chronic CNI nephrotoxicity contributes to loss of kidneys in the long term, the author reviews data from the last 3 decades to understand the issues of today. See rhetorical viewpoint by Matas on page 687.

  8. Original Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. Clinical Science

      You have free access to this content
      The Histology of Solitary Renal Allografts at 1 and 5 Years After Transplantation (pages 698–707)

      M. D. Stegall, W. D. Park, T. S. Larson, J. M. Gloor, L. D. Cornell, S. Sethi, P. G. Dean, M. Prieto, H. Amer, S. Textor, T. Schwab and F. G. Cosio

      Version of Record online: 9 NOV 2010 | DOI: 10.1111/j.1600-6143.2010.03312.x

      • image
      • image
      • image

      This study of protocol renal allograft biopsies suggests that chronic histologic changes at 5 years are less severe than previously reported, and that mild fibrosis present at 1 year does not commonly progress to more severe forms. See editorial by Brouard et al on page 647.

    2. You have free access to this content
      The Molecular Phenotype of 6-Week Protocol Biopsies from Human Renal Allografts: Reflections of Prior Injury but Not Future Course (pages 708–718)

      M. Mengel, J. Chang, D. Kayser, W. Gwinner, A. Schwarz, G. Einecke, V. Broecker, K. Famulski, D. G. de Freitas, L. Guembes-Hidalgo, B. Sis, H. Haller and P. F. Halloran

      Version of Record online: 29 NOV 2010 | DOI: 10.1111/j.1600-6143.2010.03339.x

      • image
      • image
      • image
      • image

      The molecular phenotype in 6-week protocol biopsies correlates with subclinical infiltrates and tubulitis by histology, but shows a strong association with prior DGF but not future outcome. See editorial by Brouard et al on page 647.

    3. You have free access to this content
      Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches (pages 719–724)

      J. M. Cecka, A. Y. Kucheryavaya, N. L. Reinsmoen and M. S. Leffell

      Version of Record online: 29 NOV 2010 | DOI: 10.1111/j.1600-6143.2010.03340.x

      • image

      The virtual crossmatch has substantially reduced the number of deceased donor kidney offers that are declined in the US because of a positive actual crossmatch, and has improved the access to transplants for sensitized candidates. See editorial by Bray et al on page 650.

    4. You have free access to this content
      Associations of Body Mass Index and Weight Loss with Mortality in Transplant-Waitlisted Maintenance Hemodialysis Patients (pages 725–736)

      M. Z. Molnar, E. Streja, C. P. Kovesdy, S. Bunnapradist, M. S. Sampaio, J. Jing, M. Krishnan, A. R. Nissenson, G. M. Danovitch and K. Kalantar-Zadeh

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03468.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image

      The authors examined the association of changes in pretransplant BMI or muscle mass with mortality in 14,632 hemodialysis patients over 6 years of kidney transplant waitlisting period (2001–2007) and found that lower BMI or muscle mass and/or unintentional weight or muscle loss were associated with higher mortality. See editorial by Segev et al on page 652.

    5. You have free access to this content
      Living Kidney Donors: Impact of Age on Long-Term Safety (pages 737–742)

      L. F. C. Dols, N. F. M. Kok, J. I. Roodnat, T. C. K. Tran, T. Terkivatan, W. C. Zuidema, W. Weimar and J. N. M. IJzermans

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03465.x

      • image
      • image
      • image

      Live kidney donation by the elderly is considered, demonstrating that the decline in eGFR is similar in younger and older donors.

    6. You have free access to this content
      Accepting Kidneys from Older Living Donors: Impact on Transplant Recipient Outcomes (pages 743–750)

      A. Young, S. J. Kim, M. R. Speechley, A. Huang, G. A. Knoll, G. V. Ramesh Prasad, D. Treleaven, M. Diamant, A. X. Garg and for the Donor Nephrectomy Outcomes Research (DONOR) Network

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03442.x

      • image

      Based on analysis of large Canadian healthcare databases, recipients of older living donor kidneys had 4-year total graft survival similar to recipients of standard criteria deceased donor kidneys, but showed a trend towards potential differences when compared to recipients of younger living donor kidneys.

    7. You have free access to this content
      Improved Survival with Recent Post-Transplant Lymphoproliferative Disorder (PTLD) in Children with Kidney Transplants (pages 751–758)

      V. R. Dharnidharka, K. L. Martz, D. M. Stablein and M. R. Benfield

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03470.x

      • image
      • image
      • image
      • image

      This study demonstrates improved patient survival in more recent cases of posttransplant lymphoproliferative disease cases, with relatively worse survival in cases that occurred beyond 1 year postransplant or in older children.

    8. You have free access to this content
      Operative Risks of Domino Liver Transplantation for the Familial Amyloid Polyneuropathy Liver Donor and Recipient: A Double Analysis (pages 759–766)

      G. Tincani, E. Hoti, P. Andreani, L. Ricca, G. Pittau, V. Vitale, F. Blandin, R. Adam, D. Castaing and D. Azoulay

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03477.x

      This study of domino liver transplantation shows that familial amyloid polyneuropathy donors are not exposed to higher operative risks compared to nondonor patients, and recipients of such grafts have no higher operative risks compared to cadaveric liver recipients.

    9. You have free access to this content
      Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting (pages 767–774)

      J. Dragun, S. Pérez-del-Pulgar, G. Crespo, S. Ramírez, M. Coto-Llerena, L. Mensa, J. C. García-Valdecasas, M. Navasa and X. Forns

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03440.x

      • image
      • image
      • image

      This study of liver allograft recipients with hepatitis C virus suggests that viral adaptation may account for early viral kinetics following liver transplantation.

    10. You have free access to this content
      Characterization of HCV-Specific CD4+Th17 Immunity in Recurrent Hepatitis C–Induced Liver Allograft Fibrosis (pages 775–785)

      H. I. Basha, V. Subramanian, A. Seetharam, D. S. Nath, S. Ramachandran, C. D. Anderson, S. Shenoy, W. C. Chapman, J. S. Crippin and T. Mohanakumar

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03458.x

      • image
      • image
      • image
      • image
      • image
      • image

      This study demonstrates that recurrent hepatitis C virus infection following orthotopic liver transplantation leads to increased IL-6, IL-1β and decreased IFN-γ which induces hepatitis C virus specific CD4+Th17 cells, which may play a role in allograft fibrosis and cirrhosis.

    11. You have free access to this content
      rPSGL-Ig for Improvement of Early Liver Allograft Function: A Double-Blind, Placebo-Controlled, Single-Center Phase II Study (pages 786–797)

      R. W. Busuttil, G. S. Lipshutz, J. W. Kupiec-Weglinski, S. Ponthieux, D. W. Gjertson, C. Cheadle, T. Watkins, E. Ehrlich, E. Katz, E. C. Squiers, H. Rabb and S. Hemmerich

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03441.x

      • image
      • image
      • image
      • image

      Treatment with rPSGL-Ig, a P-selectin antagonist, improved early liver allograft function in a double-blinded, placebo-controlled, single-center Phase II study, in association with decreased IP-10 and augmented IL-10 expression.

    12. You have free access to this content
      The Economic Implications of Broader Sharing of Liver Allografts (pages 798–807)

      D. A. Axelrod, A. Gheorghian, M. A. Schnitzler, N. Dzebisashvili, P. R. Salvalaggio, J. Tuttle-Newhall, D. L. Segev, S. Gentry, S. Hohmann, R. M. Merion and K. L. Lentine

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03443.x

      • image
      • image

      Use of national registry and integrated cost accounting data to assess the economic impact of alternative liver allograft sharing simulations supports the premise that broader sharing of liver allografts offers a cost-effective strategy to reduce the mortality from end-stage liver disease.

    13. You have free access to this content
      Long-Term Follow-Up in Composite Tissue Allotransplantation: In-Depth Study of Five (Hand and Face) Recipients (pages 808–816)

      P. Petruzzo, J. Kanitakis, L. Badet, J.-B. Pialat, S. Boutroy, R. Charpulat, J. Mouly, A. Gazarian, M. Lanzetta, M. Brunet, B. Devauchelle, S. Testelin, X. Martin, J. M. Dubernard and E. Morelon

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03469.x

      • image
      • image
      • image
      • image
      • image

      Using the available technology to study four bilateral hand allografts and a partial facial allograft, the authors did not find evidence of chronic immune mediated graft injury.

    14. You have free access to this content
      Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients (pages 817–825)

      R. Reshef, M.R. Luskin, M. Kamoun, S. Vardhanabhuti, J. E. Tomaszewski, E. A. Stadtmauer, D. L. Porter, D. F. Heitjan and De. E. Tsai

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03454.x

      • image
      • image

      The authors analyze a large cohort of solid organ transplant recipients and demonstrate novel associations between specific HLA polymorphisms and the risk to develop post-transplant lymphoproliferative disease.

  9. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Coexpression of Donor Peptide/Recipient MHC Complex and Intact Donor MHC: Evidence for a Link between the Direct and Indirect Pathways (pages 826–831)

      K. Brown, S. H. Sacks and W. Wong

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03437.x

      • image
      • image
      • image
      • image
      • image

      Donor passenger leukocytes exchange MHC molecules with the recipient, resulting in antigen presenting cells expressing both donor and recipient MHC; this includes recipient MHC molecules presenting donor derived allopeptides, thus providing a link between the direct and indirect antigen presentation pathways.

    2. You have free access to this content
      Essential Role of PDL1 Expression on Nonhematopoietic Donor Cells in Acquired Tolerance to Vascularized Cardiac Allografts (pages 832–840)

      L. V. Riella, T. Watanabe, P. T. Sage, J. Yang, M. Yeung, J. Azzi, V. Vanguri, A. Chandraker, A. H. Sharpe, M. H. Sayegh and N. Najafian

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03451.x

      • image
      • image
      • image
      • image
      • image
      • image

      PDL1 expression on nonhematopoietic donor cells, particularly endothelium, plays an essential role in controlling the alloimmune response and in inducing tolerance in vascularized cardiac allografts.

    3. You have free access to this content
      Donor-Directed MHC Class I Antibody Is Preferentially Cleared from Sensitized Recipients of Combined Liver/Kidney Transplants (pages 841–847)

      W. Dar, A. Agarwal, C. Watkins, H. M. Gebel, R. A. Bray, K. E. Kokko, T. C. Pearson and S. J. Knechtle

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03467.x

      • image

      Donor-directed MHC class I antibody is preferentially cleared, relative to class II antibody, in sensitized recipients of combined liver/kidney transplants.

    4. You have free access to this content
      Organ Donor Screening Practices for Trypanosoma cruzi Infection among US Organ Procurement Organizations (pages 848–851)

      B. S. Schwartz, M. Paster, M. G. Ison and P. V. Chin-Hong

      Version of Record online: 22 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03436.x

      • image
      • image

      All US organ procurement organizations responded to a survey describing their donor screening practices for Trypanosoma cruzi infection and organ utilization from seropositive donors.

  10. Case Reports

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Renal Transplantation for Fibromuscular Dysplasia (pages 852–856)

      N. B. B. Knops, E. A. M. Cornelissen and L. A. H. Monnens

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03455.x

      • image

      The authors report a case in which a living related renal transplantation was performed as rescue treatment for therapy-resistant renovascular hypertension due to fibromuscular dysplasia.

    2. You have free access to this content
      The Importance of Portal Venous Blood Flow in Ischemic-Type Biliary Lesions after Liver Transplantation (pages 857–862)

      W. R. R. Farid, J. de Jonge, J. C. Slieker, P. E. Zondervan, M. G. J. Thomeer, H. J. Metselaar, R. W. F. de Bruin and G. Kazemier

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03438.x

      • image
      • image
      • image
      • image
      • image

      This study describes the relation between the development of post–liver transplant portal vein thrombosis and ischemic-type biliary lesions, revealing portal vein thrombosis as a risk factor for developing ischemic-type biliary lesions.

  11. Reports from the CDC: MMWR

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Potential Transmission of Viral Hepatitis Through Use of Stored Blood Vessels as Conduits in Organ Transplantation—Pennsylvania, 2009 (pages 863–865)

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03522.x

      As detailed in this report, stored vessels from donors with hepatitis may be a potential source of donor-derived hepatitis when used in transplant recipients.

  12. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      The Need for Better Understanding of Transplant Glomerulitis (page 866)

      A. Haririan and J.C. Papadimitriou

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03453.x

    2. You have free access to this content
      Chronic Lymphocytic Leukemia in Kidney Recipients (pages 867–868)

      G. d'Ythurbide, D. Dierickx and A. Hertig

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03439.x

    3. You have free access to this content
      A Rare Variation of the Biliary Tree of Relevance to Live Liver Donation (pages 869–870)

      T. Iida, T. Kaido, A. Yoshizawa, S. Yagi, K. Hata, Y. Ogura, A. Mori, H. Isoda and S. Uemoto

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03457.x

      • image
    4. You have free access to this content
      A Picture Is Worth a Thousand Words (pages 871–872)

      R. G. McGee and L. M. McGee

      Version of Record online: 14 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03459.x

      • image
  13. Errata

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorials
    5. Minireviews
    6. Special Articles
    7. Meeting Report
    8. Personal Viewpoints
    9. Original Articles
    10. Brief Communications
    11. Case Reports
    12. Reports from the CDC: MMWR
    13. Letters to the Editor
    14. Errata
    1. You have free access to this content
      Erratum (page 873)

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03527.x

      This article corrects:
    2. You have free access to this content
      Erratum (page 874)

      Version of Record online: 29 MAR 2011 | DOI: 10.1111/j.1600-6143.2011.03528.x

      This article corrects:

      The Long-Term Quality of Life of Living Kidney Donors: A Multicenter Cohort Study

      Vol. 11, Issue 3, 463–469, Version of Record online: 22 FEB 2011

SEARCH

SEARCH BY CITATION